Clincosm LogoSign in Get a demo

Understanding Allergies and Sensitizations in Healthy and Allergic Individuals

Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04828603
Collaborator
National Institutes of Health (NIH) (NIH), Crown Fundation (Other), Sunshine Foundation (Other)
2,000
Enrollment
1
Location
218
Anticipated Duration (Months)
9.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to strengthen our ability to accurately diagnose allergies and understand cellular, humoral, genetic components and physiological changes in allergic disease

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    2000 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Understanding Allergies
    Actual Study Start Date :
    Oct 1, 2007
    Anticipated Primary Completion Date :
    Dec 1, 2025
    Anticipated Study Completion Date :
    Dec 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Skin testing to evaluate food allergen responses [1 year]

      Standardized skin testing performed to detect sensitivity to allergens of interest

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Week to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Any individual with possible allergy
    Exclusion Criteria:
    • Patients with special risks attendant to venipuncture will be excluded

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sean N. Parker Center for Allergy and Asthma Research, Stanford University Mountain View California United States 94040

    Sponsors and Collaborators

    • Stanford University
    • National Institutes of Health (NIH)
    • Crown Fundation
    • Sunshine Foundation

    Investigators

    • Principal Investigator: R. Sharon Chinthrajah, MD, Stanford University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    R. Sharon Chinthrajah, Associate Professor & Director, Clinical Translational Research Unit, Stanford University
    ClinicalTrials.gov Identifier:
    NCT04828603
    Other Study ID Numbers:
    • 8629
    First Posted:
    Apr 2, 2021
    Last Update Posted:
    Sep 10, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Hypersensitivity

    Study Results

    No Results Posted as of Sep 10, 2021